<DOC>
	<DOCNO>NCT00192153</DOCNO>
	<brief_summary>The purpose clinical study evaluate immune response measure antibody serum secretion cellular immune response generate CAIV-T vaccine healthy adult age 18 year old mean develop assays application investigate potential immunological correlate protection and/or establish assays measure vaccine take .</brief_summary>
	<brief_title>Trial Investigate Immune Responses Elicited Liquid Formulation Influenza Virus Vaccine ( CAIV-T ) Healthy Adults Aged 18 59 Healthy Adults Aged 60 Years Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Healthy adult age 18 59 year &gt; 60 year . Female subject childbearing potential negative urine pregnancy test result prior study vaccination . Females surgically sterile postmenopausal require pregnancy test . Adults determine medical history , physical examination clinical judgment eligible study . Subjects stable preexist disease , define disease require change therapy hospitalization within 12 week receipt study vaccination , eligible . Subjects provide write informed consent nature study explain . Subjects available duration study ( enrollment study completion ) . Subjects could reach study staff postvaccination contact [ via telephone , clinic home visit ] . For subject &gt; 60 year age : Subjects reside nursing home longterm care facility institution receive skilled semiskilled nursing care . An ambulatory subject reside retirement home village eligible participation . Subjects evidence dementia severe cognitive impairment base Mini Mental State Examination ( MMSE ) score . Note : Prior study vaccination , subject &gt; 60 year age must complete MMSE . For study subject : Subjects perceive unavailable difficult contact evaluation study visit study period . Subjects know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ; cytotoxic agent . Subjects reside household immunosuppressed immunocompromised individual . Subjects document history hypersensitivity egg egg protein component study vaccine , placebo TIV . Subjects current wheezing episode consider change subject â€™ usual clinical state .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>